急性反復発作薬の世界市場（～2026年）

• 英文タイトル：Global Acute Repetitive Seizures Drugs Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY13568
• 出版社/出版日：QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は急性反復発作薬のグローバル市場について調査・分析したレポートです。種類別（注射、胃腸、その他）市場規模、用途別（病院、研究所、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別急性反復発作薬の競争状況、市場シェア
・世界の急性反復発作薬市場：種類別市場規模 2015年-2020年（注射、胃腸、その他）
・世界の急性反復発作薬市場：種類別市場規模予測 2021年-2026年（注射、胃腸、その他）
・世界の急性反復発作薬市場：用途別市場規模 2015年-2020年（病院、研究所、薬局、その他）
・世界の急性反復発作薬市場：用途別市場規模予測 2021年-2026年（病院、研究所、薬局、その他）
・北米の急性反復発作薬市場分析：米国、カナダ
・ヨーロッパの急性反復発作薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの急性反復発作薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の急性反復発作薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの急性反復発作薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Union Chimique Belge (UCB)、Neurelis、Bausch Health、Alexza Pharmaceuticals、Veriton Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Acute Repetitive Seizures Drugs Market
The global Acute Repetitive Seizures Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Acute Repetitive Seizures Drugs Scope and Market Size
Acute Repetitive Seizures Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Repetitive Seizures Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Union Chimique Belge (UCB)
Neurelis
Bausch Health
Alexza Pharmaceuticals
Veriton Pharma
…

Market segment by Type, the product can be split into
Injections
Gastrointestinal
Other
Market segment by Application, split into
Hospitals
Research Laboratories
Pharmacies
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Repetitive Seizures Drugs Revenue
1.4 Market by Type
1.4.1 Global Acute Repetitive Seizures Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Injections
1.4.3 Gastrointestinal
1.4.4 Other
1.5 Market by Application
1.5.1 Global Acute Repetitive Seizures Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Research Laboratories
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Acute Repetitive Seizures Drugs Market Perspective (2015-2026)
2.2 Global Acute Repetitive Seizures Drugs Growth Trends by Regions
2.2.1 Acute Repetitive Seizures Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Repetitive Seizures Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Acute Repetitive Seizures Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Repetitive Seizures Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Repetitive Seizures Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Acute Repetitive Seizures Drugs Players by Market Size
3.1.1 Global Top Acute Repetitive Seizures Drugs Players by Revenue (2015-2020)
3.1.2 Global Acute Repetitive Seizures Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Repetitive Seizures Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Repetitive Seizures Drugs Market Concentration Ratio
3.2.1 Global Acute Repetitive Seizures Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Repetitive Seizures Drugs Revenue in 2019
3.3 Acute Repetitive Seizures Drugs Key Players Head office and Area Served
3.4 Key Players Acute Repetitive Seizures Drugs Product Solution and Service
3.5 Date of Enter into Acute Repetitive Seizures Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Acute Repetitive Seizures Drugs Historic Market Size by Type (2015-2020)
4.2 Global Acute Repetitive Seizures Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)
5.2 Global Acute Repetitive Seizures Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Acute Repetitive Seizures Drugs Market Size (2015-2020)
6.2 Acute Repetitive Seizures Drugs Key Players in North America (2019-2020)
6.3 North America Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
6.4 North America Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Acute Repetitive Seizures Drugs Market Size (2015-2020)
7.2 Acute Repetitive Seizures Drugs Key Players in Europe (2019-2020)
7.3 Europe Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
7.4 Europe Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

8 China
8.1 China Acute Repetitive Seizures Drugs Market Size (2015-2020)
8.2 Acute Repetitive Seizures Drugs Key Players in China (2019-2020)
8.3 China Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
8.4 China Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Acute Repetitive Seizures Drugs Market Size (2015-2020)
9.2 Acute Repetitive Seizures Drugs Key Players in Japan (2019-2020)
9.3 Japan Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
9.4 Japan Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Acute Repetitive Seizures Drugs Market Size (2015-2020)
10.2 Acute Repetitive Seizures Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

11 India
11.1 India Acute Repetitive Seizures Drugs Market Size (2015-2020)
11.2 Acute Repetitive Seizures Drugs Key Players in India (2019-2020)
11.3 India Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
11.4 India Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Acute Repetitive Seizures Drugs Market Size (2015-2020)
12.2 Acute Repetitive Seizures Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Repetitive Seizures Drugs Market Size by Type (2015-2020)
12.4 Central & South America Acute Repetitive Seizures Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Union Chimique Belge (UCB)
13.1.1 Union Chimique Belge (UCB) Company Details
13.1.2 Union Chimique Belge (UCB) Business Overview
13.1.3 Union Chimique Belge (UCB) Acute Repetitive Seizures Drugs Introduction
13.1.4 Union Chimique Belge (UCB) Revenue in Acute Repetitive Seizures Drugs Business (2015-2020))
13.1.5 Union Chimique Belge (UCB) Recent Development
13.2 Neurelis
13.2.1 Neurelis Company Details
13.2.2 Neurelis Business Overview
13.2.3 Neurelis Acute Repetitive Seizures Drugs Introduction
13.2.4 Neurelis Revenue in Acute Repetitive Seizures Drugs Business (2015-2020)
13.2.5 Neurelis Recent Development
13.3 Bausch Health
13.3.1 Bausch Health Company Details
13.3.2 Bausch Health Business Overview
13.3.3 Bausch Health Acute Repetitive Seizures Drugs Introduction
13.3.4 Bausch Health Revenue in Acute Repetitive Seizures Drugs Business (2015-2020)
13.3.5 Bausch Health Recent Development
13.4 Alexza Pharmaceuticals
13.4.1 Alexza Pharmaceuticals Company Details
13.4.2 Alexza Pharmaceuticals Business Overview
13.4.3 Alexza Pharmaceuticals Acute Repetitive Seizures Drugs Introduction
13.4.4 Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Drugs Business (2015-2020)
13.4.5 Alexza Pharmaceuticals Recent Development
13.5 Veriton Pharma
13.5.1 Veriton Pharma Company Details
13.5.2 Veriton Pharma Business Overview
13.5.3 Veriton Pharma Acute Repetitive Seizures Drugs Introduction
13.5.4 Veriton Pharma Revenue in Acute Repetitive Seizures Drugs Business (2015-2020)
13.5.5 Veriton Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Acute Repetitive Seizures Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Repetitive Seizures Drugs Revenue
Table 3. Ranking of Global Top Acute Repetitive Seizures Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Repetitive Seizures Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Injections
Table 6. Key Players of Gastrointestinal
Table 7. Key Players of Other
Table 8. Global Acute Repetitive Seizures Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Acute Repetitive Seizures Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Acute Repetitive Seizures Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Acute Repetitive Seizures Drugs Market Share by Regions (2015-2020)
Table 12. Global Acute Repetitive Seizures Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Acute Repetitive Seizures Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Acute Repetitive Seizures Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Acute Repetitive Seizures Drugs Players
Table 19. Global Acute Repetitive Seizures Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Acute Repetitive Seizures Drugs Market Share by Players (2015-2020)
Table 21. Global Top Acute Repetitive Seizures Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures Drugs as of 2019)
Table 22. Global Acute Repetitive Seizures Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Acute Repetitive Seizures Drugs Product Solution and Service
Table 25. Date of Enter into Acute Repetitive Seizures Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 28. Global Acute Repetitive Seizures Drugs Market Size Share by Type (2015-2020)
Table 29. Global Acute Repetitive Seizures Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Acute Repetitive Seizures Drugs Market Size Share by Application (2015-2020)
Table 31. Global Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Acute Repetitive Seizures Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 35. North America Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. North America Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 37. North America Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 41. Europe Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 43. Europe Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 47. China Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. China Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 49. China Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 53. Japan Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 55. Japan Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 59. Southeast Asia Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 61. Southeast Asia Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 65. India Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. India Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 67. India Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Acute Repetitive Seizures Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Acute Repetitive Seizures Drugs Market Share (2019-2020)
Table 71. Central & South America Acute Repetitive Seizures Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Acute Repetitive Seizures Drugs Market Share by Type (2015-2020)
Table 73. Central & South America Acute Repetitive Seizures Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Acute Repetitive Seizures Drugs Market Share by Application (2015-2020)
Table 75. Union Chimique Belge (UCB) Company Details
Table 76. Union Chimique Belge (UCB) Business Overview
Table 77. Union Chimique Belge (UCB) Product
Table 78. Union Chimique Belge (UCB) Revenue in Acute Repetitive Seizures Drugs Business (2015-2020) (Million US$)
Table 79. Union Chimique Belge (UCB) Recent Development
Table 80. Neurelis Company Details
Table 81. Neurelis Business Overview
Table 82. Neurelis Product
Table 83. Neurelis Revenue in Acute Repetitive Seizures Drugs Business (2015-2020) (Million US$)
Table 84. Neurelis Recent Development
Table 85. Bausch Health Company Details
Table 86. Bausch Health Business Overview
Table 87. Bausch Health Product
Table 88. Bausch Health Revenue in Acute Repetitive Seizures Drugs Business (2015-2020) (Million US$)
Table 89. Bausch Health Recent Development
Table 90. Alexza Pharmaceuticals Company Details
Table 91. Alexza Pharmaceuticals Business Overview
Table 92. Alexza Pharmaceuticals Product
Table 93. Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Drugs Business (2015-2020) (Million US$)
Table 94. Alexza Pharmaceuticals Recent Development
Table 95. Veriton Pharma Company Details
Table 96. Veriton Pharma Business Overview
Table 97. Veriton Pharma Product
Table 98. Veriton Pharma Revenue in Acute Repetitive Seizures Drugs Business (2015-2020) (Million US$)
Table 99. Veriton Pharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Repetitive Seizures Drugs Market Share by Type: 2020 VS 2026
Figure 2. Injections Features
Figure 3. Gastrointestinal Features
Figure 4. Other Features
Figure 5. Global Acute Repetitive Seizures Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Research Laboratories Case Studies
Figure 8. Pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Acute Repetitive Seizures Drugs Report Years Considered
Figure 11. Global Acute Repetitive Seizures Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acute Repetitive Seizures Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Acute Repetitive Seizures Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acute Repetitive Seizures Drugs Market Share by Players in 2019
Figure 16. Global Top Acute Repetitive Seizures Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acute Repetitive Seizures Drugs Revenue in 2019
Figure 18. North America Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acute Repetitive Seizures Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

急性反復発作の世界市場（～2026年）

Global Acute Repetitive Seizures Market Size, Status and Forecast 2020-2026
MRC2-11QY13569 2020年11月30日 95Pages
当調査資料は急性反復発作のグローバル市場について調査・分析したレポートです。種類別（USL-261、NRL-1、AZ-002、ジアゼパム直腸ゲル、その他）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

強直間代発作の世界市場（～2026年）

Global Tonic-Clonic Seizures Market Size, Status and Forecast 2020-2026
MRC2-11QY04863 2020年11月20日 93Pages
当調査資料は強直間代発作のグローバル市場について調査・分析したレポートです。種類別（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他）市場規模、用途別（病院、診療所、学術研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロ...

急性骨髄性白血病治療薬の世界市場（～2026年）

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13565 2020年11月30日 96Pages
当調査資料は急性骨髄性白血病治療薬のグローバル市場について調査・分析したレポートです。種類別（パイプライン薬、化学療法薬、化学療法レジメン）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

急性腎不全治療薬の世界市場（～2026年）

Global Acute Renal Failure Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13567 2020年11月30日 99Pages
当調査資料は急性腎不全治療薬のグローバル市場について調査・分析したレポートです。種類別（重炭酸ナトリウム、N-アセチルシステイン、スタチン、その他）市場規模、用途別（病院、診療所、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

急性虚血性脳卒中治療薬の世界市場（～2026年）

Global Acute Ischemic Stroke Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13563 2020年11月30日 98Pages
当調査資料は急性虚血性脳卒中治療薬のグローバル市場について調査・分析したレポートです。種類別（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

急性冠症候群（ACS）の世界市場（～2026年）

Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2020-2026
MRC2-11QY13561 2020年11月30日 92Pages
当調査資料は急性冠症候群（ACS）のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

急性冠症候群治療薬の世界市場（～2026年）

Global Acute Coronary Syndrome Therapeutics Market Insights and Forecast to 2026
MRC2-11QY02086 2020年11月20日 111Pages
当調査資料は急性冠症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（急性冠症候群第I相薬、急性冠症候群第II相薬、急性冠症候群第III相薬）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

急性脊髄損傷の世界市場（～2026年）

Global Acute Spinal Cord Injury Market Size, Status and Forecast 2020-2026
MRC2-11QY13571 2020年11月30日 93Pages
当調査資料は急性脊髄損傷のグローバル市場について調査・分析したレポートです。種類別（実験室検査、画像検査）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

救急治療センターの世界市場（～2026年）

Global Acute Care Centers Market Size, Status and Forecast 2020-2026
MRC2-11QY13559 2020年11月30日 93Pages
当調査資料は救急治療センターのグローバル市場について調査・分析したレポートです。種類別（プライマリケアセンター、病院救急治療室、自立型救急治療室、冠状動脈・集中治療室、新生児集中治療室）市場規模、用途別（65歳以上、55歳-65歳、45歳-55歳、45歳以下）市場規模、地域別（北米、米国、カナダ、ヨ...

急性骨髄性白血病の世界市場（～2026年）

Global Acute Myeloid Leukemia Market Size, Status and Forecast 2020-2026
MRC2-11QY13564 2020年11月30日 93Pages
当調査資料は急性骨髄性白血病のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、小売ドラッグストア、外来診療センター、腫瘍センター、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

急性反復発作の世界市場（～2026年） Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG. Market Analysis and Insights: Global Acute Repetitive Seizures Market The global Acute Repetitive Seizures market size is projected to reach US$ 245.3 million by 2026, from US$ 174.4 million in 2020, at…
強直間代発作の世界市場（～2026年） Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic …
急性骨髄性白血病治療薬の世界市場（～2026年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
急性冠症候群（ACS）の世界市場（～2026年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…